The ramifications of HLA-B27

Journal of the Royal Society of Medicine

Volumn 97, Issue 1, 2004, Pages 10-14

  Sheehan, Nicholas J ^a  

^a EDITH CAVELL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTHROPATHY; DISEASE ASSOCIATION; ENTHESITIS; GENETIC SUSCEPTIBILITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROORGANISM; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REITER SYNDROME; REVIEW; SCREENING TEST; SPONDYLOARTHROPATHY; STRUCTURE ANALYSIS; UNITED KINGDOM; UVEITIS;

EID: 1642471712     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.97.1.10     Document Type: Review

References (50)

1. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6
2. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD. Ankylosing spondylitis and HL-A27. Lancet 1973;i:904-7
3. Moll JMH, Haslock I, Macrae IF, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behçet's syndrome. Medicine (Baltimore) 1974;53:343-64
4. Keat AC, Maini RN, Nkwazi GC, Pegrum GD, Ridgway GL, Scott JT. Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. BMJ 1978;i:605-7
5. Olivieri I, Gemignani G, Gherardi S, Grassi L, Ciompi ML. Isolated HLA-B27 associated Achilles tendinitis. Ann Rheum Dis 1987;46:626-7
6. Feldman M. Southern Internal Medicine Conference: Whipple's disease. Am J Med Sci 1986;291:56-67
7. Yazici H. Behçet's syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, eds. Oxford Textbook of Rheumatology, 2nd edn. Oxford: Oxford University Press, 1998:1394-402
8. Khan AK. A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog JD, eds. The Spondylarthritides. Oxford: Oxford University Press, 1998:17-26
9. Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY. Features of spondyloarthritis around the world. Rheum Dis Clin N Am 1998;24:753-70
10. Khan MA, Ball EJ. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002;16:675-90
11. van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241-9
12. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67
13. Brown MA, Pile KD, Kennedy LG, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998;41:588-95
14. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8
15. Laval SH, Timms A, Edwards S, et al. Whole genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26
16. Laval SH, Bradbury L, Darke C, Brophy S, Calin A, Brown MA. The role of HLA-DR genes in ankylosing spondylitis complicating inflammatory bowel disease. Rheumatology 2000:39(abstr suppl): A115
17. Hoyle E, Laval SH, Calin A, Wordsworth BP, Brown MA. The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum 2000;43:1353-5
18. Ebringer RW, Cawdell DR, Cowling P, Ebringer A. Sequential studies in ankylosing spondylitis: association of Klebsiella pneumoniae with active disease. Ann Rheum Dis 1978;37:146-51
19. Saarinen M, Ekman P, Ikeda M, et al. Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology 2002;41:651-7
20. Keat A, Thomas B, Dixey J, Osborn M, Sonnex C, Taylor-Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1987;i:72-4
21. Lahesmaa-Rantala R, Granfors K, Isomaki H, Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis 1987;46:510-14
22. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology 2002;41:857-68
23. Bowness P. HLA and the spondylarthropathies. In: Lechler R, Warrens A, eds. HLA in Health and Disease, 2nd edn. San Diego: Academic Press, 2000:187-94
24. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099-112
25. Cauli A, Dessole G, Fiorillo MT, et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology 2002;41:1375-9
26. Linssen A, Rothova A, Valkenburg HA. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991;32:2568-78
27. Pulido JS, Streilein JW. HLA and eye disease. In: Lechler R, Warrens A, eds. HLA in Health and Disease, 2nd edn. San Diego: Academic Press, 2000:279-97
28. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin N Am 1992;18:143-50
29. Friedmann A. HLA and dermatological disease. In: Lechler R, Warrens A, eds. HLA in Health and Disease, 2nd edn. San Diego: Academic Press, 2000:365-86
30. Rahman P, Schentag CT, Gladman DD. Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis. Arthritis Rheum 1999;42:822-3
31. Williamson L, Dockerty J, Dalbeth N, et al. Patterns of skin disease in psoriatic arthritis and associations with HLA-B27. Rheumatology 2002;41(abstr suppl 1):A315
32. Merchant JA, Klouda PT, Soutar CA. The HLA system in asbestos workers. BMJ 1975;i:189-91
33. Evans CC, Lewinsohn HC, Evans JM. Frequency of HLA antigen in asbestos workers with and without pulmonary fibrosis. BMJ 1977;i:603-5
34. Huuskonen MS, Tiilikainen A, Alanko K. HLA-B18 antigens and protection from pulmonary fibrosis in asbestos workers. Br J Dis Chest 1979;73:253-9
35. Hillerdal G, Safvenberg J. HLA B27: a risk factor for lung disease? Lancet 1983;ii:1195
36. Horslev-Petersen K, Helin P. HLA-B27: a risk factor for lung disease? Lancet 1984;i:104
37. Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med 1997;127:621-9
38. Au WY, Hawkins BR, Cheng N, Lie AKW, Liang R, Kwong YL. Risk of haematological malignancies in HLA-B27 carriers. Br J Haematol 2001;115:320-2
39. Njobvu P, McGill P, Kerr H, Jellis J, Pobee J. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998;25:1553-9
40. Goulder PJR, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-17
41. Khan MA, Khan MK. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Intern Med 1982;96:70-6
42. Amor B, Dougados M, Mijiyawa M. Critère diagnostique des spondylarthropathies. Rev Rheum Mal Osteoartic 1990;57:85-9
43. Brophy S, Hamersma J, Bradbury L, et al. Towards defining the genetic determinants of disease severity in ankylosing spondylitis. Rheumatology 2001;40(abstr suppl 1):A48
44. Queiro R, Belzunegui J, Gonzalez C, De Dios JR, Barastay E, Figueroa M. The HLA-B27 antigen may determine the susceptibility to and the clinical expression of psoriatic spondyloarthropathy. Rheumatology 2001;40(abstr suppl 1):A128
45. Leirisalo M, Skylv G, Kousa M, et al. Follow up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25:249-59
46. Leirisalo-Repo M, Helenius P, Hannu T, et al. Long term prognosis of reactive salmonella arthritis. Ann Rheum Dis 1997;56:516-20
47. Bas S, Kvien TK, Buchs N, Fulpius T, Gabay C. Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology 2003;42:461-7
48. Morris AJ, Morris CR. Is the presence of HLA B-27 a predisposing factor to poor outcomes in back surgery? Arthritis Rheum 1995;38:251
49. Jaraquemada D, Ollier W, Awad J, et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986;45:627-36
50. Ollier W, Pepper L, Thomson W. HLA-B27 as a marker for developing subluxations of the cervical spine in RA. Arthritis Rheum 1994;37(suppl):A1017